193 related articles for article (PubMed ID: 2981106)
1. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
[TBL] [Abstract][Full Text] [Related]
2. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
McCray E
N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
[TBL] [Abstract][Full Text] [Related]
3. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
[TBL] [Abstract][Full Text] [Related]
4. HTLV-III infection among health care workers. Association with needle-stick injuries.
Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD
JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694
[TBL] [Abstract][Full Text] [Related]
5. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
6. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
7. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.
Henderson DK; Saah AJ; Zak BJ; Kaslow RA; Lane HC; Folks T; Blackwelder WC; Schmitt J; LaCamera DJ; Masur H
Ann Intern Med; 1986 May; 104(5):644-7. PubMed ID: 3963663
[TBL] [Abstract][Full Text] [Related]
8. Virologic studies in a case of transfusion-associated AIDS.
Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P
N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957
[TBL] [Abstract][Full Text] [Related]
9. HTLV-III AIDS link.
Bennett JA
Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
[TBL] [Abstract][Full Text] [Related]
10. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.
Ho DD; Rota TR; Schooley RT; Kaplan JC; Allan JD; Groopman JE; Resnick L; Felsenstein D; Andrews CA; Hirsch MS
N Engl J Med; 1985 Dec; 313(24):1493-7. PubMed ID: 2999591
[TBL] [Abstract][Full Text] [Related]
11. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
12. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
[TBL] [Abstract][Full Text] [Related]
13. A pathogenic retrovirus (HTLV-III) linked to AIDS.
Broder S; Gallo RC
N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
[TBL] [Abstract][Full Text] [Related]
15. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
17. Screening for AIDS.
Med Lett Drugs Ther; 1985 Mar; 27(684):29-30. PubMed ID: 2984526
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
20. HTLV-III infection in Canada in 1985.
Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]